help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2004-0101
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tiffin, N.
Right arrow Articles by Rosenthal, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tiffin, N.
Right arrow Articles by Rosenthal, S. M.
Endocrinology Vol. 145, No. 11 4991-4996
Copyright © 2004 by The Endocrine Society

Akt Phosphorylation Is Not Sufficient for Insulin-Like Growth Factor-Stimulated Myogenin Expression but Must Be Accompanied by Down-Regulation of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Phosphorylation

Nicki Tiffin, Saleh Adi, David Stokoe, Nan-Yan Wu and Stephen M. Rosenthal

Department of Pediatrics (N.T., S.A., N.-Y.W., S.M.R.), University of California San Francisco, San Francisco, California 94143; and Cancer Research Institute (D.S.), University of California San Francisco, San Francisco, California 94115

Address all correspondence and requests for reprints to: Stephen M. Rosenthal, Department of Pediatrics, Box 0434, University of California San Francisco, San Francisco, California 94143-0434. E-mail: smr{at}itsa ucsf.edu.

IGF-I has a unique biphasic effect on skeletal muscle differentiation. Initially, IGF-I inhibits expression of myogenin, a skeletal muscle-specific regulatory factor essential for myogenesis. Subsequently, IGF-I switches to stimulating expression of myogenin. The mechanisms that mediate this switch in IGF action are incompletely understood. Several laboratories have demonstrated that the phosphatidylinositol-3-kinase/Akt signaling pathway is essential for myogenic differentiation and have suggested that this pathway mediates IGF-I stimulation of myogenin mRNA expression, an early critical step in the differentiation process. These studies, however, did not address concurrent Akt and MAPK/ERK1/2 phosphorylation, the latter of which is also known to regulate myogenic differentiation. In the present study in rat L6E9 muscle cells, we have manipulated ERK1/2 phosphorylation with either an upstream inhibitor or activator and examined concurrent levels of Akt and ERK1/2 phosphorylation and of myogenin mRNA expression in response to treatment with IGF-I. We find that even in the presence of phosphorylated Akt, it is only when ERK1/2 phosphorylation is inhibited that IGF-I can stimulate myogenin mRNA expression. Thus, although Akt phosphorylation may be necessary, it is not sufficient for induction of myogenic differentiation by IGF-I and must be accompanied by a decrease in ERK1/2 phosphorylation.




This article has been cited by other articles:


Home page
EndocrinologyHome page
C. De Alvaro, I. Nieto-Vazquez, J. M. Rojas, and M. Lorenzo
Nuclear Exclusion of Forkhead Box O and Elk1 and Activation of Nuclear Factor-{kappa}B Are Required for C2C12-RasV12C40 Myoblast Differentiation
Endocrinology, February 1, 2008; 149(2): 793 - 801.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
V. Odemis, K. Boosmann, M. T. Dieterlen, and J. Engele
The chemokine SDF1 controls multiple steps of myogenesis through atypical PKC{zeta}
J. Cell Sci., November 15, 2007; 120(22): 4050 - 4059.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S.-E. Chen, B. Jin, and Y.-P. Li
TNF-{alpha} regulates myogenesis and muscle regeneration by activating p38 MAPK
Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1660 - C1671.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
V. Jacquemin, G. S. Butler-Browne, D. Furling, and V. Mouly
IL-13 mediates the recruitment of reserve cells for fusion during IGF-1-induced hypertrophy of human myotubes
J. Cell Sci., February 15, 2007; 120(4): 670 - 681.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Zhan, B. Jin, S.-E. Chen, J. M. Reecy, and Y.-P. Li
TACE release of TNF-{alpha} mediates mechanotransduction-induced activation of p38 MAPK and myogenesis
J. Cell Sci., February 15, 2007; 120(4): 692 - 701.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
E. Edstrom, M. Altun, M. Hagglund, and B. Ulfhake
Atrogin-1/MAFbx and MuRF1 Are Downregulated in Aging-Related Loss of Skeletal Muscle.
J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2006; 61(7): 663 - 674.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society